Nuvectra

Nuvectra company information, Employees & Contact Information

Explore related pages

Related company profiles:

First and only pulse to pulse Closed- Loop SCS system in the world.

Company Details

Employees
17
Founded
-
Address
5830 Granite Parkway, Suite 1100, Plano,tx 75024,united States
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Plano, TX
Looking for a particular Nuvectra employee's phone or email?

Nuvectra Questions

News

Saluda Medical Appoints Barry Regan as Chief Executive Officer - PR Newswire

Saluda Medical Appoints Barry Regan as Chief Executive Officer PR Newswire

Saluda Medical Announces Closing of $100 Million Financing - PR Newswire

Saluda Medical Announces Closing of $100 Million Financing PR Newswire

Saluda Medical picks former Dexcom exec as CEO - MassDevice

Saluda Medical picks former Dexcom exec as CEO MassDevice

Saluda Medical announces EVA sensing technology launch in US - Medical Device Network

Saluda Medical announces EVA sensing technology launch in US Medical Device Network

Saluda Medical Receives FDA Approval for First Automated Programming Platform in SCS - PR Newswire

Saluda Medical Receives FDA Approval for First Automated Programming Platform in SCS PR Newswire

Saluda Medical raises $100M for closed-loop neuromod - MassDevice

Saluda Medical raises $100M for closed-loop neuromod MassDevice

Saluda Medical Announces Executive Leadership Changes - PR Newswire

Saluda Medical Announces Executive Leadership Changes PR Newswire

Saluda Medical Announces Late Breaking Data at NANS 2024 Annual Meeting - PR Newswire

Saluda Medical Announces Late Breaking Data at NANS 2024 Annual Meeting PR Newswire

Saluda Medical Announces Full U.S. Launch of EVA™ Sensing Technology for Use with the Evoke® SmartLoop™ System - PR Newswire

Saluda Medical Announces Full U.S. Launch of EVA™ Sensing Technology for Use with the Evoke® SmartLoop™ System PR Newswire

Saluda Medical Announces Presentation of 36-Month Trial Data at NANS 2023 Annual Meeting - PR Newswire

Saluda Medical Announces Presentation of 36-Month Trial Data at NANS 2023 Annual Meeting PR Newswire

Saluda Medical Initiates U.S. Commercialization of the Evoke® Spinal Cord Stimulation System - PR Newswire

Saluda Medical Initiates U.S. Commercialization of the Evoke® Spinal Cord Stimulation System PR Newswire

Saluda Medical the First to Present 24-Month Holistic Response to Spinal Cord Stimulation - PR Newswire

Saluda Medical the First to Present 24-Month Holistic Response to Spinal Cord Stimulation PR Newswire

Saluda Medical Appoints Robert Palmisano to Board of Directors - PR Newswire

Saluda Medical Appoints Robert Palmisano to Board of Directors PR Newswire

Saluda Medical Appoints Jim Erickson as Chief Financial Officer - PR Newswire

Saluda Medical Appoints Jim Erickson as Chief Financial Officer PR Newswire

Saluda Medical Announces $150M Equity Financing Led by Wellington Management with Fidelity Management & Research Company and TPG - PR Newswire

Saluda Medical Announces $150M Equity Financing Led by Wellington Management with Fidelity Management & Research Company and TPG PR Newswire

Saluda Medical Receives FDA Approval for the Evoke® Spinal Cord Stimulation System to Treat Chronic Intractable Pain - PR Newswire

Saluda Medical Receives FDA Approval for the Evoke® Spinal Cord Stimulation System to Treat Chronic Intractable Pain PR Newswire

Saluda Medical Receives FDA Approval for Evoke® System MRI Labeling - PR Newswire

Saluda Medical Receives FDA Approval for Evoke® System MRI Labeling PR Newswire

Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group - PR Newswire

Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group PR Newswire

Saluda Medical Secures AU$53 Million in Series D Financing - PR Newswire

Saluda Medical Secures AU$53 Million in Series D Financing PR Newswire

Electrophysiological Responses in the Human S3 Nerve During Sacral Neuromodulation for Fecal Incontinence - Frontiers

Electrophysiological Responses in the Human S3 Nerve During Sacral Neuromodulation for Fecal Incontinence Frontiers

Saluda Medical launches beauty parade, upsizes IPO to $US200m - The Australian

Saluda Medical launches beauty parade, upsizes IPO to $US200m The Australian

Saluda Medical float hopes rise with investor pitch - The Australian

Saluda Medical float hopes rise with investor pitch The Australian

Top Nuvectra Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant